Neuroinflammation in intracerebral haemorrhage: immunotherapies with potential for translation

Gross, 2019, Cerebral intraparenchymal hemorrhage: a review, JAMA, 321, 1295, 10.1001/jama.2019.2413 Wan, 2019, Iron toxicity, lipid peroxidation and ferroptosis after intracerebral haemorrhage, Stroke Vasc Neurol, 4, 93, 10.1136/svn-2018-000205 Bai, 2020, Microglia and macrophage phenotypes in intracerebral haemorrhage injury: therapeutic opportunities, Brain, 143, 1297, 10.1093/brain/awz393 Tschoe, 2020, Neuroinflammation after intracerebral hemorrhage and potential therapeutic targets, J Stroke, 22, 29, 10.5853/jos.2019.02236 Shtaya, 2019, Rapid neuroinflammatory changes in human acute intracerebral hemorrhage, Ann Clin Transl Neurol, 6, 1465, 10.1002/acn3.50842 Jiang, 2020, Immune changes in peripheral blood and hematoma of patients with intracerebral hemorrhage, FASEB J, 34, 2774, 10.1096/fj.201902478R Yong, 2005, Metalloproteinases: mediators of pathology and regeneration in the CNS, Nat Rev Neurosci, 6, 931, 10.1038/nrn1807 Lattanzi, 2020, Matrix metalloproteinases in acute intracerebral hemorrhage, Neurotherapeutics, 17, 484, 10.1007/s13311-020-00839-0 Zhang, 2015, Nuclear factor-κB activation in perihematomal brain tissue correlates with outcome in patients with intracerebral hemorrhage, J Neuroinflammation, 12, 53, 10.1186/s12974-015-0277-9 Rodríguez-Yáñez, 2012, Increased expression of toll-like receptors 2 and 4 is associated with poor outcome in intracerebral hemorrhage, J Neuroimmunol, 247, 75, 10.1016/j.jneuroim.2012.03.019 Mackenzie, 1999, Early cellular events in the penumbra of human spontaneous intracerebral hemorrhage, J Stroke Cerebrovasc Dis, 8, 1, 10.1016/S1052-3057(99)80032-9 Kayhanian, 2017, Prognostic value of peripheral leukocyte counts and plasma glucose in intracerebral haemorrhage, J Clin Neurosci, 41, 50, 10.1016/j.jocn.2017.03.032 Wimmer, 2018, Neuroinflammatory responses in experimental and human stroke lesions, J Neuroimmunol, 323, 10, 10.1016/j.jneuroim.2018.07.003 Mracsko, 2014, Leukocyte invasion of the brain after experimental intracerebral hemorrhage in mice, Stroke, 45, 2107, 10.1161/STROKEAHA.114.005801 Zhang, 2018, Organ- and cell-specific immune responses are associated with the outcomes of intracerebral hemorrhage, FASEB J, 32, 220, 10.1096/fj.201700324r Dong, 2019, When encephalitogenic T cells collaborate with microglia in multiple sclerosis, Nat Rev Neurol, 15, 704, 10.1038/s41582-019-0253-6 Liddelow, 2017, Neurotoxic reactive astrocytes are induced by activated microglia, Nature, 541, 481, 10.1038/nature21029 Li, 2010, Perihematomal pathological changes in neurons and astrocytes following acute cerebral hemorrhage, Int J Neurosci, 120, 683, 10.3109/00207454.2010.513460 Katsanos, 2017, Plasma glial fibrillary acidic protein in the differential diagnosis of intracerebral hemorrhage, Stroke, 48, 2586, 10.1161/STROKEAHA.117.018409 Luger, 2017, Glial fibrillary acidic protein serum levels distinguish between intracerebral hemorrhage and cerebral ischemia in the early phase of stroke, Clin Chem, 63, 377, 10.1373/clinchem.2016.263335 Duan, 2016, Intracerebral hemorrhage, oxidative stress, and antioxidant therapy, Oxid Med Cell Longev, 2016, 10.1155/2016/1203285 Lorente, 2018, Serum malondialdehyde levels and mortality in patients with spontaneous intracerebral hemorrhage, World Neurosurg, 113, e542, 10.1016/j.wneu.2018.02.085 Chang, 2014, Matrix metalloproteinase-9: dual role and temporal profile in intracerebral hemorrhage, J Stroke Cerebrovasc Dis, 23, 2498, 10.1016/j.jstrokecerebrovasdis.2014.07.005 Rosell, 2006, Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke, Stroke, 37, 1399, 10.1161/01.STR.0000223001.06264.af Zhang, 2010, Exploring the optimal operation time for patients with hypertensive intracerebral hemorrhage: tracking the expression and progress of cell apoptosis of prehematomal brain tissues, Chin Med J (Engl), 123, 1246 Wu, 2008, Expression of matrix metalloproteinase MMP-9 in the plasma and hematoma fluid of intracerebral hemorrhage patients, Zhonghua Yi Xue Za Zhi, 88, 174 Abilleira, 2003, Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage, J Neurosurg, 99, 65, 10.3171/jns.2003.99.1.0065 Lorente, 2020, High serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with spontaneous intracerebral hemorrhage, World Neurosurg, 134, e476, 10.1016/j.wneu.2019.10.106 Zhao, 2006, Role of matrix metalloproteinases in delayed cortical responses after stroke, Nat Med, 12, 441, 10.1038/nm1387 Zhu, 2019, Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage, Prog Neurobiol, 178, 10.1016/j.pneurobio.2019.03.003 Malone, 2019, Immunomodulatory therapeutic strategies in stroke, Front Pharmacol, 10, 630, 10.3389/fphar.2019.00630 Yong, 2019, The benefits of neuroinflammation for the repair of the injured central nervous system, Cell Mol Immunol, 16, 540, 10.1038/s41423-019-0223-3 Sansing, 2011, Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage, Ann Neurol, 70, 646, 10.1002/ana.22528 Taylor, 2017, TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage, J Clin Invest, 127, 280, 10.1172/JCI88647 Shi, 2015, Increased frequency of circulating regulatory T cells in patients with acute cerebral hemorrhage, Neurosci Lett, 591, 115, 10.1016/j.neulet.2015.02.042 Faissner, 2018, Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?, Mult Scler, 24, 1543, 10.1177/1352458517728811 Sheng, 2018, Efficacy of minocycline in acute ischemic stroke: a systematic review and meta-analysis of rodent and clinical studies, Front Neurol, 9, 10.3389/fneur.2018.01103 Yrjänheikki, 1998, Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia, Proc Natl Acad Sci USA, 95, 15769, 10.1073/pnas.95.26.15769 Yong, 2004, The promise of minocycline in neurology, Lancet Neurol, 3, 744, 10.1016/S1474-4422(04)00937-8 Naderi, 2020, Neuroprotective effects of minocycline on focal cerebral ischemia injury: a systematic review, Neural Regen Res, 15, 773, 10.4103/1673-5374.268898 Kobayashi, 2013, Minocycline selectively inhibits M1 polarization of microglia, Cell Death Dis, 4, e525, 10.1038/cddis.2013.54 Power, 2003, Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases, Ann Neurol, 53, 731, 10.1002/ana.10553 Xue, 2010, Improving outcomes of neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in mice, Am J Pathol, 176, 1193, 10.2353/ajpath.2010.090361 Selim, 2019, Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial, Lancet Neurol, 18, 428, 10.1016/S1474-4422(19)30069-9 Fouda, 2017, Minocycline in acute cerebral hemorrhage: an early phase randomized trial, Stroke, 48, 2885, 10.1161/STROKEAHA.117.018658 Chang, 2017, Minocycline and matrix metalloproteinase inhibition in acute intracerebral hemorrhage: a pilot study, Eur J Neurol, 24, 1384, 10.1111/ene.13403 Casha, 2012, Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury, Brain, 135, 1224, 10.1093/brain/aws072 Lampl, 2007, Minocycline treatment in acute stroke: an open-label, evaluator-blinded study, Neurology, 69, 1404, 10.1212/01.wnl.0000277487.04281.db Padma Srivastava, 2012, Efficacy of minocycline in acute ischemic stroke: a single-blinded, placebo-controlled trial, Neurol India, 60, 23, 10.4103/0028-3886.93584 Cudkowicz, 2010, A futility study of minocycline in Huntington's disease, Mov Disord, 25, 2219, 10.1002/mds.23236 Gordon, 2007, Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial, Lancet Neurol, 6, 1045, 10.1016/S1474-4422(07)70270-3 Howard, 2020, Minocycline at 2 different dosages vs placebo for patients with mild Alzheimer disease: a randomized clinical trial, JAMA Neurol, 77, 164, 10.1001/jamaneurol.2019.3762 Metz, 2017, Trial of minocycline in a clinically isolated syndrome of multiple sclerosis, N Engl J Med, 376, 2122, 10.1056/NEJMoa1608889 O'Sullivan, 2016, Sphingosine-1-phosphate receptor therapies: advances in clinical trials for CNS-related diseases, Neuropharmacology, 113, 597, 10.1016/j.neuropharm.2016.11.006 Noda, 2013, Fingolimod phosphate promotes the neuroprotective effects of microglia, J Neuroimmunol, 256, 13, 10.1016/j.jneuroim.2012.12.005 Rolland, 2013, Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage, Exp Neurol, 241, 45, 10.1016/j.expneurol.2012.12.009 Lu, 2014, Fingolimod exerts neuroprotective effects in a mouse model of intracerebral hemorrhage, Brain Res, 1555, 89, 10.1016/j.brainres.2014.01.048 Zhang, 2017, T lymphocytes infiltration promotes blood-brain barrier injury after experimental intracerebral hemorrhage, Brain Res, 1670, 96, 10.1016/j.brainres.2017.06.019 Fu, 2014, Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study, JAMA Neurol, 71, 1092, 10.1001/jamaneurol.2014.1065 Li, 2015, Fingolimod alters inflammatory mediators and vascular permeability in intracerebral hemorrhage, Neurosci Bull, 31, 755, 10.1007/s12264-015-1532-2 Zhu, 2015, Combination of the immune modulator fingolimod with alteplase in acute ischemic stroke: a pilot trial, Circulation, 132, 1104, 10.1161/CIRCULATIONAHA.115.016371 Bobinger, 2019, Siponimod (BAF-312) attenuates perihemorrhagic edema and improves survival in experimental intracerebral hemorrhage, Stroke, 50, 3246, 10.1161/STROKEAHA.119.027134 Shakeri-Nejad, 2020, Safety, tolerability, pharmacodynamics and pharmacokinetics of intravenous siponimod: a randomized, open-label study in healthy subjects, Clin Ther, 42, 175, 10.1016/j.clinthera.2019.11.014 Arefieva, 2018, Immunotropic effects and proposed mechanism of action for 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (Statins), Biochemistry (Mosc), 83, 874, 10.1134/S0006297918080023 Ewen, 2013, Neuroprotective effect of atorvastatin involves suppression of TNF-α and upregulation of IL-10 in a rat model of intracerebral hemorrhage, Cell Biochem Biophys, 66, 337, 10.1007/s12013-012-9453-z Wang, 2018, The evolving role of neuro-immune interaction in brain repair after cerebral ischemic stroke, CNS Neurosci Ther, 24, 1100, 10.1111/cns.13077 Tapia-Perez, 2009, Use of statins for the treatment of spontaneous intracerebral hemorrhage: results of a pilot study, Cent Eur Neurosurg, 70, 15, 10.1055/s-0028-1082064 Chen, 2019, Statins for neuroprotection in spontaneous intracerebral hemorrhage, Neurology, 93, 1056, 10.1212/WNL.0000000000008627 Ribe, 2019, Statins and risk of intracerebral haemorrhage in a stroke-free population: a nationwide Danish propensity score matched cohort study, EClinicalMedicine, 8, 78, 10.1016/j.eclinm.2019.02.007 Åsberg, 2020, Statins as secondary preventives in patients with intracerebral hemorrhage, Int J Stroke, 15, 61, 10.1177/1747493018816476 Yadav, 2019, Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis, J Mol Med (Berl), 97, 463, 10.1007/s00109-019-01761-5 Zhao, 2015, Dimethyl fumarate protects brain from damage produced by intracerebral hemorrhage by mechanism involving Nrf2, Stroke, 46, 1923, 10.1161/STROKEAHA.115.009398 Elkins, 2017, Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial, Lancet Neurol, 16, 217, 10.1016/S1474-4422(16)30357-X Elkind, 2020, Natalizumab in acute ischemic stroke (ACTION II): a randomized, placebo-controlled trial, Neurology, 95, e1091, 10.1212/WNL.0000000000010038 Lei, 2016, Neuroprotective pentapeptide CN-105 improves functional and histological outcomes in a murine model of intracerebral hemorrhage, Sci Rep, 6, 10.1038/srep34834 Xu, 2019, Glibenclamide ameliorates the disrupted blood-brain barrier in experimental intracerebral hemorrhage by inhibiting the activation of NLRP3 inflammasome, Brain Behav, 9, 10.1002/brb3.1254 Liddle, 2020, Translational intracerebral hemorrhage research: has current neuroprotection research ARRIVEd at a standard for experimental design and reporting?, Transl Stroke Res, 10.1007/s12975-020-00824-x Lively, 2012, Age-related comparisons of evolution of the inflammatory response after intracerebral hemorrhage in rats, Transl Stroke Res, 3, 132, 10.1007/s12975-012-0151-3 Fu, 2015, Immune interventions in stroke, Nat Rev Neurol, 11, 524, 10.1038/nrneurol.2015.144